candesartan cilexetil has been researched along with Retinal Neovascularization in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Retinal Neovascularization: Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, H | 1 |
| Inoue, T | 1 |
| Arakawa, N | 1 |
| Shimizu, Y | 1 |
| Yoshigae, Y | 1 |
| Fujimori, I | 1 |
| Shimakawa, E | 1 |
| Toyoshi, T | 1 |
| Yokoyama, T | 1 |
1 other study available for candesartan cilexetil and Retinal Neovascularization
| Article | Year |
|---|---|
Pharmacological and pharmacokinetic study of olmesartan medoxomil in animal diabetic retinopathy models.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Area Under Curve; Benzimidazoles; Biphenyl Compoun | 2005 |